Introduction: Hereditary Elliptocytosis (HE) comprises clinically and genetically heterogeneous red cell membranopathies resulting from defects in the horizontal linkage between red blood cell (RBC) membrane and cytoskeletal proteins, which affect mechanical stability and deformability, thereby reducing RBC lifespan. The principal defect in HE is due to dysfunction or deficiency of RBC cytoskeletal proteins.
Case Description: This study reported a case of severe hemolysis occurring within one day after birth in a term newborn. High-throughput sequencing was used to characterize the pathogenic gene variation in this child and to study the correlation between the identified variation and its corresponding phenotypic characteristics.
Conclusion: HE is caused by monoallelic mutations, which justify the phenotypic heterogeneity observed in patients. Furthermore, molecular analysis using high-throughput sequencing enables diagnosis in disorders with highly variable heterogeneity. HE can also present with severe hemolysis during the neonatal period.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534593 | PMC |
| http://dx.doi.org/10.3389/fped.2024.1485318 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A rare case report of hemolysis in a newborn: hereditary elliptocytosis.
Front Pediatr
October 2024
Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Introduction: Hereditary Elliptocytosis (HE) comprises clinically and genetically heterogeneous red cell membranopathies resulting from defects in the horizontal linkage between red blood cell (RBC) membrane and cytoskeletal proteins, which affect mechanical stability and deformability, thereby reducing RBC lifespan. The principal defect in HE is due to dysfunction or deficiency of RBC cytoskeletal proteins.
Case Description: This study reported a case of severe hemolysis occurring within one day after birth in a term newborn.
Trans-acting genetic modifiers of clinical severity in heterozygous β-Thalassemia trait.
Ann Hematol
November 2024
Division of Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
There is a group of beta (β)-thalassemia trait 'carriers' (with heterozygous mutations) who should be asymptomatic with minor abnormalities in their hematological parameters, but experience more severe disease manifestations than predicted based solely on their β-globin genotype. This review focuses on literature describing trans-acting genetic modifiers outside of the α- and β-globin gene clusters that could cause this phenomenon. These genetic modifiers are categorized into: mutations affecting the quantity of alpha-globin products, non-globin mutations affecting erythropoiesis, membranopathies, enzymopathies and erythrocyte-independent modifiers of complications relating to β-thalassemia.
View Article and Find Full Text PDFA Case Report of Hemolytic Hyponatremia.
Cureus
February 2024
Internal Medicine, Hospital Universitario del Valle "Evaristo García" - Universidad del Valle, Cali, COL.
Hereditary spherocytosis/elliptocytosis is a non-immune hemolytic anemia caused by an alteration in the erythrocyte membrane that predisposes the cell to its lysis. This report presents a case of a 42-year-old woman with a history of spontaneous abortion, associated with postpartum bleeding, chronic anemia, and premature menopause. After five years, she consulted due to alterations in the state of consciousness and severe symptomatic hyponatremia, with a diagnosis of hypopituitarism, explained by a late Sheehan syndrome.
View Article and Find Full Text PDF[Effect of Staphylococcal Nuclease and Tudor Domain Containing 1/SLC7A11 on the Occurrence and Development of Osteosarcoma by Inhibiting Ferroptosis].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
February 2024
Department of Joint Surgery and Sports Medicine, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin,Guangxi 541002,China.
Article Synopsis
- This study examined how staphylococcal nuclease and tudor domain containing 1 (SND1) influences osteosarcoma cell behavior and its role in ferroptosis regulation through SLC7A11.
- Key methods included using human osteoblasts and various osteosarcoma cell lines, where SND1 expression was analyzed and knocked down to assess its effects on cell viability, proliferation, and migration.
- Findings revealed that higher SND1 levels in osteosarcoma cells correlated with increased viability, while its knockdown reduced cell growth and enhanced ferroptosis, indicating a potential target for osteosarcoma treatment.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!